Bupropion Impurity 19 | CAS 2700324-50-9 - Request Quote
Bupropion Impurity 19
| SZ CAT No: | SZ-B001063 |
| CAS No | 2700324-50-9 |
| Mol.F. | C12H14ClNO3S |
| Mol.Wt. | 287.8 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
CHNS Ratio (%) :
Usage Note:
Bupropion Impurity 19 is chemically 6-(3-Chlorophenyl)-6-hydroxy-5-methylthiomorpholine-3-carboxylic acid. Bupropion Impurity 19 is supplied with detailed characterization data compliant with regulatory guideline. Bupropion Impurity 19 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Bupropion.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2700324-50-9
Purchase 2700324-50-9
Order 2700324-50-9
Enquire 2700324-50-9
price of 2700324-50-9
2700324-50-9 Supplier
2700324-50-9 Manufacturer
2700324-50-9 Exporter
buy high quality Bupropion Impurity 19
Purchase Bupropion Impurity 19
Bupropion Impurity 19 suppliers
Bupropion Impurity 19 manufacturers
Bupropion Impurity 19 price
Order Bupropion Impurity 19
Enquire Bupropion Impurity 19
Bupropion Impurity 19 cost
Bupropion Impurity 19 Supplier
Bupropion Impurity 19 Distributor
Bupropion Impurity 19 for Method Validation
Bupropion Reference Standard
Bupropion Impurity 19 for ANDA Filing
Bupropion Impurity 19 for Forced Degradation Studies
Bupropion Impurity 19 Identification Standards
Bupropion Impurity 19 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.